Techniques: Application of systems biology to absorption, distribution, metabolism, excretion and toxicity

Trends in Pharmacological Sciences

Volumn 26, Issue 4, 2005, Pages 202-209

  Ekins, Sean ^a   Nikolsky, Yuri ^a   Nikolskaya, Tatiana ^a  

^a GeneGo bioinformatics software Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; HORMONE RECEPTOR; PARACETAMOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ABSORPTION; ALGORITHM; DATA ANALYSIS; DNA DAMAGE; DNA MICROARRAY; DRUG OVERDOSE; EXCRETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC CODE; INTEGRATION; INTERNET; MEDICAL INFORMATION; METABOLISM; METABOLOMICS; MOLECULAR MODEL; NONHUMAN; PHARMACOGENOMICS; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEOMICS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; RISK ASSESSMENT; TOXICOGENETICS; TOXICOLOGY;

EID: 15944425080     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2005.02.006     Document Type: Review

References (73)

1. M.D. Rawlins Cutting the cost of drug development? Nat. Rev. Drug Discov. 3 2004 360 364
2. FDA (2004) Innovation stagnation: challenge and opportunity on the critical path to new medicinal products. http://www.fda.gov/oc/initiatives/ criticalpath/whitepaper.pdf
3. S. Ekins In silico approaches to predicting metabolism, toxicology and beyond Biochem. Soc. Trans. 31 2003 611 614
4. H. van de Waterbeemd, and E. Gifford ADMET in silico modelling: towards prediction paradise? Nat. Rev. Drug Discov. 2 2003 192 204
5. S. Ekins Towards a new age of virtual ADME/TOX and multidimensional drug discovery J. Comput. Aided Mol. Des. 16 2002 381 401
6. A. Bugrim Early prediction of drug metabolism and toxicity: systems biology approach and modeling Drug Discov. Today 9 2004 127 135
7. L. Hood, and D. Galas The digital code of DNA Nature 421 2003 444 448
8. T. Ideker, and D. Lauffenburger Building with a scaffold: emerging strategies for high- to low-level cellular modeling Trends Biotechnol. 21 2003 255 262
9. S. Ekins Applying computational and in vitro approaches to lead selection R.T. Borchardt Pharmaceutical Profiling in Drug Discovery for Lead Selection 2004 AAPS Press 361 389
10. S. Ekins Generation and validation of rapid computational filters for CYP2D6 and CYP3A4 Drug Metab. Dispos. 31 2003 1077 1080
11. J. Shimada Integrating computer-based de novo drug design and multidimensional filtering for desirable drugs Targets 1 2002 196 205
12. R. Ulrich, and S.H. Friend Toxicogenomics and drug discovery: will new technologies help us produce better drugs? Nat. Rev. Drug Discov. 1 2002 84 88
13. P.G. Lord Progress in applying genomics in drug development Toxicol. Lett. 149 2004 371 375
14. Ekins, S. et al. A novel method for visualizing nuclear hormone receptor networks relevant to drug metabolism. Drug Metab. Dispos. (in press)
15. B. Yoon Mechanisms of benzene-induced hematotoxicity and leukemogenicity: cDNA microarray analyses using mouse bone marrow tissue Environ. Health Perspect. 111 2003 1411 1420
16. J.A. Kramer Acute Molecular markers of rodent hepatic carcinogenesis identified by transcription profiling Chem. Res. Toxicol. 17 2004 463 470
17. J.L. Walgren, and D.C. Thompson Application of proteomic technologies in the drug development process Toxicol. Lett. 149 2004 377 385
18. N.L. Anderson, and N.G. Anderson Proteome and proteomics: new technologies, new concepts, and new words Electrophoresis 19 1998 1853 1861
19. J.B. Klein, and V. Thongboonkerd Overview of proteomics Contrib. Nephrol. 141 2004 1 10
20. Fountoulakis, M. (2000) Two-dimensional electrophoresis. In Encyclopedia of separation science, II/electrophoresis, pp. 1356-1363, Academic Press
21. R. Aebersold, and M. Mann Mass spectrometry-based proteomics Nature 422 2003 198 207
22. H.W. Lahm, and H. Langen Mass spectrometry: a tool for the identification of proteins separated by gels Electrophoresis 21 2000 2105 2114
23. S. Kennedy The role of proteomics in toxicology: identification of biomarkers of toxicity by protein expression analysis Biomarkers 7 2002 269 290
24. G. Meneses-Lorente A proteomic investigation of drug-induced steatosis in rat liver Chem. Res. Toxicol. 17 2004 605 612
25. N. Glassbrook Metabolic profiling on the right path Nat. Biotechnol. 18 2000 1142 1143
26. J.K. Nicholson, and I.D. Wilson Understanding 'global' systems biology: metabonomics and the continuum of metabolism Nat. Rev. Drug Discov. 2 2003 668 676
27. R. Goodacre Metabolomics by numbers: acquiring and understanding global metabolite data Trends Biotechnol. 22 2004 245 252
28. W.E. Evans, and H.L. McLeod Pharmacogenomics-drug disposition, drug targets, and side effects New Engl. J. Med. 348 2003 538 549
29. R. Weinshilboum Inheritance and drug response New Engl. J. Med. 348 2003 529 537
30. R. Trotta Trends in pharmacogenomics of drugs acting on hypertension Pharmacol. Res. 49 2004 351 356
31. W.H. Heijne Toxicogenomics of bromobenzene hepatotoxicity: a combined transcriptomics and proteomics approach Biochem. Pharmacol. 65 2003 857 875
32. S.U. Ruepp Genomics and proteomics analysis of acetaminophen toxicity in mouse liver Toxicol. Sci. 65 2002 135 150
33. M. Coen Integrated application of transcriptomics and metabonomics yields new insight into the toxicity due to paracetamol in the mouse J. Pharm. Biomed. Anal. 35 2004 93 105
34. M. Fountoulakis Modulation of gene and protein expression by carbon tetrachloride in the rat liver Toxicol. Appl. Pharmacol. 183 2002 71 80
35. M.I. Klapa, and J. Quackenbush The quest for the mechanisms of life Biotechnol. Bioeng. 84 2003 739 742
36. W. Weckwerth, and O. Fiehn Can we discover novel pathways using metabolomic analysis? Curr. Opin. Biotechnol. 13 2002 156 160
37. A-L. Barabasi, and Z.N. Oltvai Network biology: understanding the cell's functional organization Nat. Rev. Genet. 5 2004 101 113
38. M.B. Eisen Cluster analysis and display of genome-wide expression patterns Proc. Natl. Acad. Sci. U. S. A. 95 1998 14863 14868
39. S. Tornow, and H.W. Mewes Functional modules by relating protein interaction networks and gene expression Nucleic Acids Res. 31 2003 6283 6289
40. D. Hanisch Co-clustering of biological networks and gene expression data Bioinformatics 18 2002 S145 S154
41. T. Ideker Discovering regulatory and signalling circuits in molecular interaction networks Bioinformatics 18 2002 S233 S240
42. E. Segal Discovering molecular pathways from protein interaction and gene expression Bioinformatics 19 2003 i264 i272
43. V. Spirin, and L.A. Mirny Protein complexes and functional modules in molecular networks Proc. Natl. Acad. Sci. U. S. A. 100 2003 12123 12128
44. M.W. Covert Integrating high-throughput and computational data elucidates bacterial networks Nature 429 2004 92 96
45. E. Werner In silico multicellular systems biology and minimal genomes Drug Discov. Today 8 2003 1121 1127
46. A. Weiss High-throughput phenotypic profiling of gene-environment interactions by quantitative growth curve analysis in Saccharomyces cerevisiae Anal. Biochem. 327 2004 23 34
47. B.R. Stockwell The biological magic behind the bullets Nat. Biotechnol. 22 2004 37 38
48. A.B. Parsons Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways Nat. Biotechnol. 22 2004 62 69
49. Ekins, S. et al. Systems biology: applications in drug discovery. In Drug Discovery Handbook (Gad, S., ed.), Wiley (in press)
50. D.E. Oliver Ontology development for a pharmacogenetics knowledge base Pac Symp Biocomput. 2002 2002 88 99
51. K. Nakata A nuclear receptor database that maps pathways to diseases Genome Infomatics 13 2002 515 516
52. Q. Yan, and W. Sadee Human membrane transporter database: a web-accessible relational database for drug transport studies and pharmacogenomics AAPS PharmSci 2 2000 E20
53. L.Z. Sun ADME-AP: a datbase of ADME associated proteins Bioinformatics 18 2002 1699 1700
54. S. Boyer, and I. Zamora New methods in predictive metabolism J. Comp. Aided Mol. Des. 16 2002 403 413
55. A.L. Castle Toxicogenomics: a new revolution in drug safety Drug Discov. Today 7 2002 728 736
56. M. Waters Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base EHP Toxicogenomics 111 2003 15 28
57. W.B. Mattes Database development in toxicogenomics: issues and efforts Environ. Health Perspect. 112 2004 495 505
58. E. Hood Proteomics: characterizing the cogs in the machinery of life Environ. Health Perspect. 111 2003 A816 A825
59. W. Tong ArrayTrack-supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research Environ. Health Perspect. 111 2003 1819 1826
60. R.S. Thomas Identification of toxicologically predictive gene sets using cDNA microarrays Mol. Pharmacol. 60 2001 1189 1194
61. J.L. Hackett, and L.J. Lesko Microarray data- the US FDA, industry and academia Nat. Biotechnol. 21 2003 742 743
62. S. Ekins, and P.W. Swaan Computational models for enzymes, transporters, channels and receptors relevant to ADME/TOX K.B. Lipkowitz Reviews in Computational Chemistry Vol. 20 2004 Wiley-VCH 333 415
63. D.E. Leahy Drug discovery information integration: virtual humans for pharmacokinetics DDT: BIOSILICO 2 2004 78 84
64. N. Greene Computer systems for the prediction of toxicity: an update Adv. Drug Deliv. Rev. 54 2002 417 431
65. D.F.V. Lewis Cytochromes P450 1996 Taylor & Francis
66. R.G. Ulrich The toxicogenomics of nuclear receptor agonists Curr. Opin. Chem. Biol. 7 2003 505 510
67. R.G. Ulrich Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression Environ. Health Perspect. 112 2004 423 427
68. D.P. Williams, and B.K. Park Idiosyncratic toxicity: the role of toxicophores and bioactivation Drug Discov. Today 8 2003 1044 1050
69. A.A. Borisy Systematic discovery of multicomponent therapeutics Proc. Natl. Acad. Sci. U. S. A. 100 2003 7977 7982
70. C.B. Clish Integrative biological analysis of the APOE*3-leiden transgenic mouse OMICS 8 2004 3 13
71. R. Christopher Data-driven computer simulation of human cancer cell Ann. New York Acad. Sci. 1020 2004 132 153
72. Z. Desta Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6 J. Pharmacol. Exp. Ther. 310 2004 1062 1075
73. T.S. Bekaii-Saab Interactions of tamoxifen, N-desmethyltamoxifen and 4-hydroxytamoxifen with P-glycoprotein and CYP3A Biopharm. Drug Dispos. 25 2004 283 289